Liver Carcinoma — Trials

Liver Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3,364 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 781
Recruiting: 463
Ph III recruiting: 41
Growth YoY: 0%
Industry share: 22%
Top sponsor: Sun Yat-sen University
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (386)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06572189	The Safety and Efficacy of CD-801 in Patients With Advanced Intrahepatic Cholangiocarcinoma	withdrawn	Early Phase 1	0	Shanghai Changzheng HospitalOTHER	1	Jun 29, 2025	clinicaltrials
NCT05111314	Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma	withdrawn	Early Phase 1	0	Mayo ClinicOTHER	1	Nov 7, 2023	clinicaltrials